Related Articles
Silencing of BAG3 promotes the sensitivity of ovarian cancer cells to cisplatin via inhibition of autophagy
BAG3-mediated Mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer
miR-100 resensitizes resistant epithelial ovarian cancer to cisplatin
Low expression of MYCN promotes cisplatin resistance by suppressing cisplatin‑induced apoptosis in epithelial ovarian cancer
ERα increases endometrial cancer cell resistance to cisplatin via upregulation of BAG3